- A systematic evaluation of the cucurbit[7]uril pharmacokinetics and toxicity after a single dose and short-term repeated administration in mice2022 | Publication without faculty affiliation
- Substituted piperazines as novel potential radioprotective agents2020 | Faculty of Medicine in Hradec Králové
- Cholinesterase Inhibitor 6-Chlorotacrine - In Vivo Toxicological Profile and Behavioural Effects2018 | Publication without faculty affiliation
- Fixed-dose combination of rosuvastatin and ezetimibe2020 | First Faculty of Medicine
- Malformations of cortical development and their epilepsy surgery2022 | Second Faculty of Medicine
- Alirocumab in treatment of combined dyslipidemia2020 | Third Faculty of Medicine
- Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers2003 | Publication without faculty affiliation
- Ten ways of using ezetimibe, or a brief guide to its use today2019 | First Faculty of Medicine
- Notes on the new "Recommendations for the treatment of dyslipidemia. Influencing of lipids to reduce cardiovascular risk"2019 | First Faculty of Medicine
- Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma2018 | First Faculty of Medicine
- Profile of patient with optimum indication for therapy with gliptins, pioglitazone and gliflozins2017 | Second Faculty of Medicine
- Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors2019 | Second Faculty of Medicine
- Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naive advanced or metastatic esophagogastric cancer2017 | Publication without faculty affiliation
- Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis2020 | Second Faculty of Medicine
- Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Science, Central Library of Charles University, Faculty of Mathematics and Physics
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome2018 | Publication without faculty affiliation